Associations between metabolomic-identified changes of biomarkers and arterial stiffness in subjects progressing to impaired fasting glucose

Saem Jung, Minjoo Kim, Young Ju Lee, Sang Hyun Lee, Jong Ho Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective We investigated correlations between age-related changes in circulating metabolites and arterial stiffness in impaired fasting glucose (IFG). Design, subjects, measurement This prospective cohort study included 602 healthy, normal fasting glucose (NFG) subjects (30-65 years old) who underwent triennial medical evaluation. After 3 years, 9·3% of subjects developed IFG (n = 56). Age, gender, BMI and fasting glucose were used to match the remaining NFG subjects (n = 546) that were included for the control group (NFG group, n = 80). Results After 3 years, levels of fasting glucose, insulin and malondialdehyde, and brachial-ankle pulse wave velocity (baPWV) were significantly greater in the IFG group than in the NFG group after adjusting for baseline values. The IFG group had a greater increase in lactosylceramide (P = 0·001, q < 0·05) and a greater reduction in phosphatidylcholine (PC) (18:0/20:4) than the NFG group. Multiple linear regression analysis showed that the change in baPWV was independently and positively associated with changes in fasting glucose and lactosylceramide. In all subjects, lactosylceramide levels positively correlated with changes in baPWV and fasting glucose, while premenopausal women were not shown, and negatively correlated with changes in PC and LDL particle size. Conclusions This study indicates that age-related increase in circulating lactosylceramide is an independent predictor of increased arterial stiffness in subjects with impaired fasting glucose.

Original languageEnglish
Pages (from-to)196-204
Number of pages9
JournalClinical Endocrinology
Volume83
Issue number2
DOIs
Publication statusPublished - 2015 Aug 1

Fingerprint

Vascular Stiffness
Metabolomics
Fasting
Biomarkers
Glucose
Pulse Wave Analysis
Ankle
Arm
Phosphatidylcholines
Malondialdehyde
Particle Size

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

@article{05b736b3a2234d5295c6faec6bd3cef6,
title = "Associations between metabolomic-identified changes of biomarkers and arterial stiffness in subjects progressing to impaired fasting glucose",
abstract = "Objective We investigated correlations between age-related changes in circulating metabolites and arterial stiffness in impaired fasting glucose (IFG). Design, subjects, measurement This prospective cohort study included 602 healthy, normal fasting glucose (NFG) subjects (30-65 years old) who underwent triennial medical evaluation. After 3 years, 9·3{\%} of subjects developed IFG (n = 56). Age, gender, BMI and fasting glucose were used to match the remaining NFG subjects (n = 546) that were included for the control group (NFG group, n = 80). Results After 3 years, levels of fasting glucose, insulin and malondialdehyde, and brachial-ankle pulse wave velocity (baPWV) were significantly greater in the IFG group than in the NFG group after adjusting for baseline values. The IFG group had a greater increase in lactosylceramide (P = 0·001, q < 0·05) and a greater reduction in phosphatidylcholine (PC) (18:0/20:4) than the NFG group. Multiple linear regression analysis showed that the change in baPWV was independently and positively associated with changes in fasting glucose and lactosylceramide. In all subjects, lactosylceramide levels positively correlated with changes in baPWV and fasting glucose, while premenopausal women were not shown, and negatively correlated with changes in PC and LDL particle size. Conclusions This study indicates that age-related increase in circulating lactosylceramide is an independent predictor of increased arterial stiffness in subjects with impaired fasting glucose.",
author = "Saem Jung and Minjoo Kim and Lee, {Young Ju} and Lee, {Sang Hyun} and Lee, {Jong Ho}",
year = "2015",
month = "8",
day = "1",
doi = "10.1111/cen.12821",
language = "English",
volume = "83",
pages = "196--204",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "2",

}

Associations between metabolomic-identified changes of biomarkers and arterial stiffness in subjects progressing to impaired fasting glucose. / Jung, Saem; Kim, Minjoo; Lee, Young Ju; Lee, Sang Hyun; Lee, Jong Ho.

In: Clinical Endocrinology, Vol. 83, No. 2, 01.08.2015, p. 196-204.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Associations between metabolomic-identified changes of biomarkers and arterial stiffness in subjects progressing to impaired fasting glucose

AU - Jung, Saem

AU - Kim, Minjoo

AU - Lee, Young Ju

AU - Lee, Sang Hyun

AU - Lee, Jong Ho

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Objective We investigated correlations between age-related changes in circulating metabolites and arterial stiffness in impaired fasting glucose (IFG). Design, subjects, measurement This prospective cohort study included 602 healthy, normal fasting glucose (NFG) subjects (30-65 years old) who underwent triennial medical evaluation. After 3 years, 9·3% of subjects developed IFG (n = 56). Age, gender, BMI and fasting glucose were used to match the remaining NFG subjects (n = 546) that were included for the control group (NFG group, n = 80). Results After 3 years, levels of fasting glucose, insulin and malondialdehyde, and brachial-ankle pulse wave velocity (baPWV) were significantly greater in the IFG group than in the NFG group after adjusting for baseline values. The IFG group had a greater increase in lactosylceramide (P = 0·001, q < 0·05) and a greater reduction in phosphatidylcholine (PC) (18:0/20:4) than the NFG group. Multiple linear regression analysis showed that the change in baPWV was independently and positively associated with changes in fasting glucose and lactosylceramide. In all subjects, lactosylceramide levels positively correlated with changes in baPWV and fasting glucose, while premenopausal women were not shown, and negatively correlated with changes in PC and LDL particle size. Conclusions This study indicates that age-related increase in circulating lactosylceramide is an independent predictor of increased arterial stiffness in subjects with impaired fasting glucose.

AB - Objective We investigated correlations between age-related changes in circulating metabolites and arterial stiffness in impaired fasting glucose (IFG). Design, subjects, measurement This prospective cohort study included 602 healthy, normal fasting glucose (NFG) subjects (30-65 years old) who underwent triennial medical evaluation. After 3 years, 9·3% of subjects developed IFG (n = 56). Age, gender, BMI and fasting glucose were used to match the remaining NFG subjects (n = 546) that were included for the control group (NFG group, n = 80). Results After 3 years, levels of fasting glucose, insulin and malondialdehyde, and brachial-ankle pulse wave velocity (baPWV) were significantly greater in the IFG group than in the NFG group after adjusting for baseline values. The IFG group had a greater increase in lactosylceramide (P = 0·001, q < 0·05) and a greater reduction in phosphatidylcholine (PC) (18:0/20:4) than the NFG group. Multiple linear regression analysis showed that the change in baPWV was independently and positively associated with changes in fasting glucose and lactosylceramide. In all subjects, lactosylceramide levels positively correlated with changes in baPWV and fasting glucose, while premenopausal women were not shown, and negatively correlated with changes in PC and LDL particle size. Conclusions This study indicates that age-related increase in circulating lactosylceramide is an independent predictor of increased arterial stiffness in subjects with impaired fasting glucose.

UR - http://www.scopus.com/inward/record.url?scp=84937164006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937164006&partnerID=8YFLogxK

U2 - 10.1111/cen.12821

DO - 10.1111/cen.12821

M3 - Article

VL - 83

SP - 196

EP - 204

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 2

ER -